Publication | Open Access
The role of PNI to predict survival in advanced hepatocellular carcinoma treated with Sorafenib
47
Citations
47
References
2020
Year
PNI represents a prognostic tool in advanced HCC treated with first-line Sorafenib. It is readily available and low-cost, and it could be implemented in clinical practice in patients with HCC.
| Year | Citations | |
|---|---|---|
Page 1
Page 1